Mark R Charbonneau

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Endothelial Cells

Radiation Therapy

Top Venues

Nature communications

Nature metabolism

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Marja K Puurunen, Jerry Vockley, Shawn L Searle, Stephanie J Sacharow, John A Phillips, William S Denney, Benjamin D Goodlett, David A Wagner, Larry Blankstein, Mary J Castillo, Mark R Charbonneau, Vincent M Isabella, Vasu V Sethuraman, Richard J Riese, Caroline B Kurtz, Aoife M Brennan
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study. Nature metabolism 3 (8) (2021)
Mark R Charbonneau, William S Denney, Nicholas G Horvath, Pasquale Cantarella, Mary J Castillo, Marja K Puurunen, Aoife M Brennan
Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria. Communications biology 4 (1) (2021)
M Tyler Nelson, Mark R Charbonneau, Heidi G Coia, Mary J Castillo, Corey Holt, Eric S Greenwood, Peter J Robinson, Elaine A Merrill, David Lubkowicz, Camilla A Mauzy
Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip. Nature communications 12 (1) (2021)
Mark R Charbonneau, Vincent M Isabella, Ning Li, Caroline B Kurtz
Developing a new class of engineered live bacterial therapeutics to treat human diseases. Nature communications 11 (1) (2020)